Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...

Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading.

Syros Pharmaceuticals, which in November said it would cut most of its workforce, is winding down operations and voluntarily delisting its stock from Nasdaq. Shares plunge 40% to 9 cents in ...

EST Syros Pharmaceuticals (SYRS) trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

EST Syros Pharmaceuticals (SYRS) trading halted, news pendingDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

The Seltos overall gains more value and the panoramic sunroof equipped model is under Rs 13 lakh. The variant line-up and the ...

Kia Syros introduces a range of innovative technologies, including a segment-first Over-the-Air (OTA) software update system.

The Kia Syros witnessed the customers preference towards the petrol-powered engine with 67 per cent of the total bookings, ...

The manual gearbox remains the preferred choice, while a considerable number of buyers opted for the automatic transmission ...

Kia India has made a strong start to 2025 with the launch of the Syros, its latest sub-compact SUV after the Sonet, which has ...

Kia has already seen over 20,000 interested buyers who have booked themselves brand-new Syros! Here is a look at the premium ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research ...